Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Autoimmune Lymphoproliferative Syndrome Type 2B
0.940 Biomarker disease BEFREE FADD deficiency sensitized more efficiently for TNFR1-mediated necroptosis than caspase-8 deficiency pointing to a caspase-8 independent inhibitory activity of FADD on TNF-induced necroptosis. 30741924 2019
Autoimmune Lymphoproliferative Syndrome Type 2B
0.940 Biomarker disease BEFREE Mixed bone marrow chimeric mice demonstrate that caspase-8 deficiency does not confer preferential expansion of synovial macrophage and dendritic cell populations, nor do caspase-8-deficient synovial populations succumb to RIPK3-mediated necroptotic death. 28978351 2017
Autoimmune Lymphoproliferative Syndrome Type 2B
0.940 GermlineCausalMutation disease ORPHANET Advances in autoimmune lymphoproliferative syndromes. 21447005 2011
Autoimmune Lymphoproliferative Syndrome Type 2B
0.940 AlteredExpression disease BEFREE Studies of patients with autoimmune lymphoproliferative syndrome (ALPS) or caspase-8 deficiency state (CEDS) demonstrated the ability of gene expression microarray analyses and small interfering RNAs (siRNA) to establish the physiologically important roles of NRAS, caspase-10, and caspase-8 for normal lymphocyte apoptosis and activation. 18818883 2009
Autoimmune Lymphoproliferative Syndrome Type 2B
0.940 GermlineCausalMutation disease ORPHANET Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome. 16446975 2006
Autoimmune Lymphoproliferative Syndrome Type 2B
0.940 GeneticVariation disease UNIPROT Thus, caspase-8 deficiency in humans is compatible with normal development and shows that caspase-8 has a postnatal role in immune activation of naive lymphocytes. 12353035 2002
Autoimmune Lymphoproliferative Syndrome Type 2B
0.940 Biomarker disease BEFREE Thus, caspase-8 deficiency in humans is compatible with normal development and shows that caspase-8 has a postnatal role in immune activation of naive lymphocytes. 12353035 2002
Autoimmune Lymphoproliferative Syndrome Type 2B
0.940 Biomarker disease MGD
Autoimmune Lymphoproliferative Syndrome Type 2B
0.940 CausalMutation disease CLINVAR
Autoimmune Lymphoproliferative Syndrome Type 2B
0.940 Biomarker disease CTD_human